Literature DB >> 19521925

Severity and outcomes of Pneumocystis pneumonia in patients newly diagnosed with HIV infection: an observational cohort study.

Matthew W Fei1, Catherine A Sant, Eunice J Kim, Alexandra Swartzman, J Lucian Davis, Leah G Jarlsberg, Laurence Huang.   

Abstract

It is unclear whether patients who are unaware of their HIV infection have different severity or outcomes of Pneumocystis pneumonia (PCP) compared to patients who have been previously diagnosed with HIV. In this retrospective observational cohort study of consecutive HIV-infected patients with microscopically diagnosed PCP at San Francisco General Hospital between 1997 and 2006, 121 of 522 patients (23%) were unaware of their HIV infection prior to their diagnosis of PCP. The proportion of patients with concurrently diagnosed HIV and PCP each year remained unchanged during the study period. Patients with newly diagnosed HIV had a significantly higher alveolar-arterial oxygen gradient at presentation (median 51 vs 45 mm Hg, p =0.03), but there were no differences in mortality, frequency of mechanical ventilation, or admission to intensive care compared to patients with previously diagnosed HIV infection. In multivariate analysis, patients who reported a sexual risk factor for HIV infection were more likely to be newly diagnosed with HIV than patients who reported injection drug use as their only HIV risk factor (odds ratio = 3.14, 95% CI 1.59-6.18, p=0.001). This study demonstrates a continued need for HIV education and earlier HIV testing, particularly in patients with high-risk sexual behavior.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19521925      PMCID: PMC2806953          DOI: 10.1080/00365540903051633

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  24 in total

1.  High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco.

Authors:  I A Binswanger; A H Kral; R N Bluthenthal; D J Rybold; B R Edlin
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

Review 2.  Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy.

Authors:  J E Kaplan; D Hanson; M S Dworkin; T Frederick; J Bertolli; M L Lindegren; S Holmberg; J L Jones
Journal:  Clin Infect Dis       Date:  2000-04       Impact factor: 9.079

3.  Prognostic markers of short-term mortality in AIDS-associated Pneumocystis carinii pneumonia.

Authors:  T L Benfield; J Helweg-Larsen; D Bang; J Junge; J D Lundgren
Journal:  Chest       Date:  2001-03       Impact factor: 9.410

4.  Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.

Authors:  J Helweg-Larsen; T L Benfield; J Eugen-Olsen; J D Lundgren; B Lundgren
Journal:  Lancet       Date:  1999-10-16       Impact factor: 79.321

5.  Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene.

Authors:  L Huang; C B Beard; J Creasman; D Levy; J S Duchin; S Lee; N Pieniazek; J L Carter; C del Rio; D Rimland; T R Navin
Journal:  J Infect Dis       Date:  2000-09-08       Impact factor: 5.226

6.  Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients.

Authors:  P Kazanjian; W Armstrong; P A Hossler; W Burman; J Richardson; C H Lee; L Crane; J Katz; S R Meshnick
Journal:  J Infect Dis       Date:  2000-07-28       Impact factor: 5.226

7.  The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia.

Authors:  J E Gallant; S M McAvinue; R D Moore; J G Bartlett; D L Stanton; R E Chaisson
Journal:  Chest       Date:  1995-04       Impact factor: 9.410

8.  Pneumocystis carinii pneumonia in HIV-infected patients in the HAART era.

Authors:  Joseph Pulvirenti; Patricia Herrera; Priya Venkataraman; Nooruzsabha Ahmed
Journal:  AIDS Patient Care STDS       Date:  2003-06       Impact factor: 5.078

9.  Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy.

Authors:  S J Dickson; S Batson; A J Copas; S G Edwards; M Singer; R F Miller
Journal:  Thorax       Date:  2007-05-21       Impact factor: 9.139

10.  Outcome of HIV-associated Pneumocystis pneumonia in hospitalized patients from 2000 through 2003.

Authors:  Saba Radhi; Travis Alexander; Michelle Ukwu; Samer Saleh; Alison Morris
Journal:  BMC Infect Dis       Date:  2008-09-16       Impact factor: 3.090

View more
  10 in total

Review 1.  New advances in understanding the host immune response to Pneumocystis.

Authors:  J Claire Hoving; Jay K Kolls
Journal:  Curr Opin Microbiol       Date:  2017-11-12       Impact factor: 7.934

Review 2.  Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches.

Authors:  Marjorie Bateman; Rita Oladele; Jay K Kolls
Journal:  Med Mycol       Date:  2020-11-10       Impact factor: 4.076

Review 3.  HIV-associated Pneumocystis pneumonia.

Authors:  Laurence Huang; Adithya Cattamanchi; J Lucian Davis; Saskia den Boon; Joseph Kovacs; Steven Meshnick; Robert F Miller; Peter D Walzer; William Worodria; Henry Masur
Journal:  Proc Am Thorac Soc       Date:  2011-06

4.  Environmental risk factors for Pneumocystis pneumonia hospitalizations in HIV patients.

Authors:  Kpandja Djawe; Linda Levin; Alexandra Swartzman; Serena Fong; Brenna Roth; Anuradha Subramanian; Katherine Grieco; Leah Jarlsberg; Robert F Miller; Laurence Huang; Peter D Walzer
Journal:  Clin Infect Dis       Date:  2012-10-05       Impact factor: 9.079

Review 5.  A Molecular Window into the Biology and Epidemiology of Pneumocystis spp.

Authors:  Liang Ma; Ousmane H Cissé; Joseph A Kovacs
Journal:  Clin Microbiol Rev       Date:  2018-06-13       Impact factor: 26.132

Review 6.  Clinical and translational research in pneumocystis and pneumocystis pneumonia.

Authors:  L Huang
Journal:  Parasite       Date:  2011-02       Impact factor: 3.000

7.  The ART of caring for patients with HIV infection in the ICU.

Authors:  Krista Powell; Laurence Huang
Journal:  Intensive Care Med       Date:  2009-07-28       Impact factor: 17.440

8.  Pulmonary coinfection by Pneumocystis jirovecii and Cryptococcus species in a patient with undiagnosed advanced HIV.

Authors:  Benjamin Valente-Acosta; José Padua-Garcia; Andrés Tame-Elorduy
Journal:  BMJ Case Rep       Date:  2020-04-14

9.  Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years.

Authors:  Julius J Schmidt; Catherina Lueck; Stefan Ziesing; Matthias Stoll; Hermann Haller; Jens Gottlieb; Matthias Eder; Tobias Welte; Marius M Hoeper; André Scherag; Sascha David
Journal:  Crit Care       Date:  2018-11-19       Impact factor: 9.097

10.  Trends in the Epidemiology and Outcomes of Pneumocystis Pneumonia among Human Immunodeficiency Virus (HIV) Hospitalizations.

Authors:  Kalaimani Elango; Mayuri Mudgal; Swetha Murthi; Prashanth Reddy Yella; Savan Nagrecha; Vedhapriya Srinivasan; Vijaykumar Sekar; Maria Koshy; Sathishkumar Ramalingam; Kulothungan Gunasekaran
Journal:  Int J Environ Res Public Health       Date:  2022-02-27       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.